WHO and the Republic of Korea have signed a Memorandum of Understanding to establish a global training hub in biomanufacturing. This global training centre will serve all low- and middle-income countries (LMICs) to produce biologicals, such as vaccines, insulin, monoclonal antibodies, and cancer medicines.
WHO and South Korea Establish Global Biomanufacturing Training Hub for Low- and Middle-Income Countries
The WHO and the Republic of Korea have signed a Memorandum of Understanding to create a global training hub in biomanufacturing aimed at supporting low- and middle-income countries in producing essential biologicals. This initiative is crucial for enhancing healthcare capabilities in countries like Iran, which may benefit from improved access to vaccine and medicine production.
👥 Key Players
📰 What Happened
The WHO and South Korea have signed an agreement to create a global training hub in biomanufacturing aimed at helping low- and middle-income countries produce essential biological products like vaccines and medicines.
- The hub will focus on training for the production of biologicals such as vaccines and cancer medicines.
- This initiative targets low- and middle-income countries, which often struggle with healthcare production capabilities.
💡 Why It Matters
📚 Background
Low- and middle-income countries often lack the infrastructure and expertise to produce essential medicines, which can lead to health crises.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%